Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04297631 · ClinicalTrials.gov registry record · Phase 4
Intraarticular Antibiotic in TKA
A Phase 4 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT04297631 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 20 participants.
The verdict
NCT04297631, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the intra-articular concentration of vancomycin and tobramycin after administration of vancomycin and tobramycin powder in primary cementless total knee arthroplasty and determine the serum concentrations of these antibiotics postoperatively.
Interventions
- DRUG Tobramycin Powder
- DEVICE Vancomyscin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-02-14 |
| Est. Completion | 2020-11-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04297631
The ClinicalTrials.gov registry entry for NCT04297631 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tobramycin Powder is the first listed.
NCT04297631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04297631 about?
NCT04297631 is a clinical study titled "Intraarticular Antibiotic in TKA". The purpose of the study is to determine the intra-articular concentration of vancomycin and tobramycin after administration of vancomycin and tobramycin powder in primary cementless total knee arthroplasty and determine the serum concentrations of these antibiotics postoperatively.
What is the current status of trial NCT04297631?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2020-02-14. Estimated completion is 2020-11-01.
What interventions are being tested in trial NCT04297631?
The interventions under investigation include: Tobramycin Powder (DRUG), Vancomyscin (DEVICE).
Who is sponsoring clinical trial NCT04297631?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.